linagliptin and empagliflozin

North America

Canada (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI (10MG+5MG) tabs
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI (25MG+5MG) tabs
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI (10MG+5MG) tabs
02459752
Boehringer Ingelheim
GLYXAMBI (25MG+5MG) tabs
02459760
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EMPAGLIFLOZIN; LINAGLIPTIN 10MG/5MG tabs
Y
oral
A10BD19
Kinapse
EMPAGLIFLOZIN; LINAGLIPTIN 25MG/5MG tabs
Y
oral
A10BD19
Kinapse
GLYXAMBI 10MG;5MG tabs
Y
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25MG;5MG tabs
Y
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EMPAGLIFLOZIN; LINAGLIPTIN 10MG/5MG tabs
212354/1
ANDA
Kinapse
EMPAGLIFLOZIN; LINAGLIPTIN 25MG/5MG tabs
212354/2
ANDA
Kinapse
GLYXAMBI 10MG;5MG tabs
206073/1
NDA
30-01-2015
Boehringer Ingelheim
GLYXAMBI 25MG;5MG tabs
206073/2
NDA
30-01-2015
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG - 5 MG fc tabs
1x
1x
-
-

oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG - 5 MG fc tabs
1x
1x
-
-

oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG - 5 MG fc tabs
1x
1x
EU/1/16/1146/009
EU/1/16/1146/002
CP
CP
Boehringer Ingelheim
GLYXAMBI 25 MG - 5 MG fc tabs
1x
1x
EU/1/16/1146/018
EU/1/16/1146/011
CP
CP
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10 MG - 5 MG fc tabs
1x
1x
Boehringer Ingelheim
GLYXAMBI 25 MG - 5 MG fc tabs
1x
1x
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI -
-
Rx
-
A10BD19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI -
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10MG/5MG fc tabs
10MG/5MG 100X1
10MG/5MG 10X1
10MG/5MG 14X1
10MG/5MG 28X1
10MG/5MG 30X1
10MG/5MG 60X1
10MG/5MG 70X1
10MG/5MG 7X1
10MG/5MG 90X1
N
N
N
N
N
N
N
N
N
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25MG/5MG fc tabs
25MG/5MG 100X1
25MG/5MG 10X1
25MG/5MG 14X1
25MG/5MG 28X1
25MG/5MG 30X1
25MG/5MG 60X1
25MG/5MG 70X1
25MG/5MG 7X1
25MG/5MG 90X1
N
N
N
N
N
N
N
N
N
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10MG/5MG fc tabs
10MG/5MG 100X1
10MG/5MG 10X1
10MG/5MG 14X1
10MG/5MG 28X1
10MG/5MG 30X1
10MG/5MG 60X1
10MG/5MG 70X1
10MG/5MG 7X1
10MG/5MG 90X1
EU/1/16/1146/009
EU/1/16/1146/002
EU/1/16/1146/003
EU/1/16/1146/004
EU/1/16/1146/005
EU/1/16/1146/006
EU/1/16/1146/007
EU/1/16/1146/001
EU/1/16/1146/008
CP
CP
CP
CP
CP
CP
CP
CP
CP
Boehringer Ingelheim
GLYXAMBI 25MG/5MG fc tabs
25MG/5MG 100X1
25MG/5MG 10X1
25MG/5MG 14X1
25MG/5MG 28X1
25MG/5MG 30X1
25MG/5MG 60X1
25MG/5MG 70X1
25MG/5MG 7X1
25MG/5MG 90X1
EU/1/16/1146/018
EU/1/16/1146/011
EU/1/16/1146/012
EU/1/16/1146/013
EU/1/16/1146/014
EU/1/16/1146/015
EU/1/16/1146/016
EU/1/16/1146/010
EU/1/16/1146/017
CP
CP
CP
CP
CP
CP
CP
CP
CP
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10MG/5MG fc tabs
10MG/5MG 100X1
10MG/5MG 10X1
10MG/5MG 14X1
10MG/5MG 28X1
10MG/5MG 30X1
10MG/5MG 60X1
10MG/5MG 70X1
10MG/5MG 7X1
10MG/5MG 90X1
0
0
0
0
0
0
0
0
0
Boehringer Ingelheim
GLYXAMBI 25MG/5MG fc tabs
25MG/5MG 100X1
25MG/5MG 10X1
25MG/5MG 14X1
25MG/5MG 28X1
25MG/5MG 30X1
25MG/5MG 60X1
25MG/5MG 70X1
25MG/5MG 7X1
25MG/5MG 90X1
0
0
0
0
0
0
0
0
0
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG+5 MG fc tabs
-
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG+5 MG fc tabs
-
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG+5 MG fc tabs
28105692515
CP
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG+5 MG fc tabs
28105692615
CP
11-11-2016
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10 MG+5 MG fc tabs
Boehringer Ingelheim
GLYXAMBI 25 MG+5 MG fc tabs
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG / 5 MG fc tabs
10 x 1 in blister
100 x 1 in blister
14 x 1 in blister
28 x 1 in blister
30 x 1 in blister
60 x 1 in blister
7 x 1 in blister
70 x 1 in blister
90 x 1 in blister
N
N
N
N
Y
N
N
N
Y
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG / 5 MG fc tabs
10 x 1 in blister
100 x 1 in blister
14 x 1 in blister
28 x 1 in blister
30 x 1 in blister
60 x 1 in blister
7 x 1 in blister
70 x 1 in blister
90 x 1 in blister
N
N
N
N
Y
N
N
N
Y
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG / 5 MG fc tabs
10 x 1 in blister
100 x 1 in blister
14 x 1 in blister
28 x 1 in blister
30 x 1 in blister
60 x 1 in blister
7 x 1 in blister
70 x 1 in blister
90 x 1 in blister
-
-
-
-
-
-
-
-
-
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG / 5 MG fc tabs
10 x 1 in blister
100 x 1 in blister
14 x 1 in blister
28 x 1 in blister
30 x 1 in blister
60 x 1 in blister
7 x 1 in blister
70 x 1 in blister
90 x 1 in blister
-
-
-
-
-
-
-
-
-
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
N
N
N
N
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
N
N
N
N
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
EU/1/16/1146/009
EU/1/16/1146/002
EU/1/16/1146/003
EU/1/16/1146/004
EU/1/16/1146/005
EU/1/16/1146/006
EU/1/16/1146/007
EU/1/16/1146/001
EU/1/16/1146/008
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
EU/1/16/1146/018
EU/1/16/1146/011
EU/1/16/1146/012
EU/1/16/1146/013
EU/1/16/1146/014
EU/1/16/1146/015
EU/1/16/1146/016
EU/1/16/1146/010
EU/1/16/1146/017
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
100x1 perf single dose blister
10x1 perf single dose blister
14x1 perf single dose blister
28x1 perf single dose blister
30x1 perf single dose blister
60x1 perf single dose blister
70x1 perf single dose blister
7x1 perf single dose blister
90x1 perf single dose blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
N
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
N
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
11-11-2016
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10 MG/5 MG fc tabs
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10/5 MG fc tabs
-
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25/5 MG fc tabs
-
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10/5 MG fc tabs
EU/1/16/1146/001-009
Boehringer Ingelheim
GLYXAMBI 25/5 MG fc tabs
EU/1/16/1146/010-018
11-11-2016
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
N100x1 dalomoji blister
N10x1 dalomoji blister
N14x1 dalomoji blister
N28x1 dalomoji blister
N30x1 dalomoji blister
N60x1 dalomoji blister
N70x1 dalomoji blister
N7x1 dalomoji blister
N90x1 dalomoji blister
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
N100x1 dalomoji blister
N10x1 dalomoji blister
N14x1 dalomoji blister
N28x1 dalomoji blister
N30x1 dalomoji blister
N60x1 dalomoji blister
N70x1 dalomoji blister
N7x1 dalomoji blister
N90x1 dalomoji blister
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
N100x1 dalomoji blister
N10x1 dalomoji blister
N14x1 dalomoji blister
N28x1 dalomoji blister
N30x1 dalomoji blister
N60x1 dalomoji blister
N70x1 dalomoji blister
N7x1 dalomoji blister
N90x1 dalomoji blister
EU/1/16/1146/009
EU/1/16/1146/002
EU/1/16/1146/003
EU/1/16/1146/004
EU/1/16/1146/005
EU/1/16/1146/006
EU/1/16/1146/007
EU/1/16/1146/001
EU/1/16/1146/008
CP
CP
CP
CP
CP
CP
CP
CP
CP
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
N100x1 dalomoji blister
N10x1 dalomoji blister
N14x1 dalomoji blister
N28x1 dalomoji blister
N30x1 dalomoji blister
N60x1 dalomoji blister
N70x1 dalomoji blister
N7x1 dalomoji blister
N90x1 dalomoji blister
EU/1/16/1146/018
EU/1/16/1146/011
EU/1/16/1146/012
EU/1/16/1146/013
EU/1/16/1146/014
EU/1/16/1146/015
EU/1/16/1146/016
EU/1/16/1146/010
EU/1/16/1146/017
CP
CP
CP
CP
CP
CP
CP
CP
CP
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
11-11-2016
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (0)
No result.
Netherlands (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/ 5 MG fc tabs
-
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/ 5 MG fc tabs
-
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/ 5 MG fc tabs
EU/1/16/1146
-
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/ 5 MG fc tabs
EU/1/16/1146
-
11-11-2016
Boehringer Ingelheim
Product
Pack
SPC
PIL
Company
GLYXAMBI 10 MG/ 5 MG fc tabs
Boehringer Ingelheim
GLYXAMBI 25 MG/ 5 MG fc tabs
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
90 x 1
-
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
90 x 1
-
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
90 x 1
01-01-2018
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
90 x 1
01-01-2018
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
-
-
-
-
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
-
-
-
-
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
CP
CP
CP
CP
CP
CP
CP
CP
CP
Boehringer Ingelheim
GLYXAMBI 25 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
CP
CP
CP
CP
CP
CP
CP
CP
CP
Boehringer Ingelheim
Product
Pack
SPC
PIL
Company
GLYXAMBI 10 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
Boehringer Ingelheim
GLYXAMBI 25 MG + 5 MG fc tabs
10 tabs
100 tabs
14 tabs
28 tabs
30 tabs
60 tabs
7 tabs
70 tabs
90 tabs
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (0)
No result.
Slovenia (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 x 1 tableto
-
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 x 1 tableto
-
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 x 1 tableto
1024-68/2016-2
CP
28-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 x 1 tableto
1024-68/2016-2
CP
28-11-2016
Boehringer Ingelheim
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 x 1 tableto
56,89
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 x 1 tableto
56,89
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 tabs
Y
Rx
oral
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 tabs
Y
Rx
oral
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 tabs
1161146005
11-07-2017
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 tabs
1161146014
07-07-2017
Boehringer Ingelheim
Product
Pack
SPC
PIL
Company
GLYXAMBI 10 MG/5 MG fc tabs
30 tabs
SPC
PIL
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
30 tabs
SPC
PIL
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG/5 MG fc tabs
Rx
-
A10BD19
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
Rx
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG/5 MG fc tabs
CP
11-11-2016
Boehringer Ingelheim
GLYXAMBI 25 MG/5 MG fc tabs
CP
11-11-2016
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GLYXAMBI 10 MG / 5 MG fc tabs
-
-
B
B
-
A10BD19
Boehringer Ingelheim
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GLYXAMBI 10 MG / 5 MG fc tabs
66132 1
66132 1
Hauptzulassung
Hauptzulassung
29-03-2017
29-03-2017
28-03-2022
28-03-2022
Boehringer Ingelheim
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.


Data source